Aluminum
Aluminium can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum Hydroxide
Aluminum hydroxide can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
aluminum hydroxide, dried (USP)
Aluminum hydroxide can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Aluminum Magnesium Silicate
Almasilate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Asenapine
Asenapine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Benazepril
Iron can cause a decrease in the absorption of Benazepril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Bismuth Subcitrate
Bismuth Subcitrate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Calcium Carbonate
Calcium Carbonate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
CALCIUM CARBONATE, PRECIPITATED
Calcium Carbonate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Advertisement
Captopril
Iron can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cefdinir
The serum concentration of Cefdinir can be decreased when it is combined with Iron.
Chlortetracycline
Chlortetracycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cilazapril
Iron can cause a decrease in the absorption of Cilazapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cimetidine
Cimetidine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cinoxacin
The serum concentration of Cinoxacin can be decreased when it is combined with Iron.
Clofezone
Rabeprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Iron.
Demeclocycline
Demeclocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dexlansoprazole
Dexlansoprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dibasic potassium phosphate
Iron can cause a decrease in the absorption of Dipotassium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dimercaprol
Dimercaprol may increase the nephrotoxic activities of Iron.
Dolutegravir
The serum concentration of Dolutegravir can be decreased when it is combined with Iron.
Doxepin
Doxepin can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxycycline
Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Doxycycline Anhydrous
Doxycycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Eltrombopag
The serum concentration of Eltrombopag can be decreased when it is combined with Iron.
Enalapril
Iron can cause a decrease in the absorption of Enalapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Enalaprilat
Iron can cause a decrease in the absorption of Enalaprilat resulting in a reduced serum concentration and potentially a decrease in efficacy.
Enalaprilat Anhydrous
Iron can cause a decrease in the absorption of Enalaprilat resulting in a reduced serum concentration and potentially a decrease in efficacy.
Enoxacin
The serum concentration of Enoxacin can be decreased when it is combined with Iron.
Epinastine
Epinastine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Esomeprazole
Esomeprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Famotidine
Famotidine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fleroxacin
The serum concentration of Fleroxacin can be decreased when it is combined with Iron.
Flumequine
The serum concentration of Flumequine can be decreased when it is combined with Iron.
Fosinopril
Iron can cause a decrease in the absorption of Fosinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gatifloxacin
The serum concentration of Gatifloxacin can be decreased when it is combined with Iron.
Gatifloxacin Anhydrous
The serum concentration of Gatifloxacin can be decreased when it is combined with Iron.
Gemifloxacin
The serum concentration of Gemifloxacin can be decreased when it is combined with Iron.
Gemifloxacin Mesylate
The serum concentration of Gemifloxacin can be decreased when it is combined with Iron.
Grepafloxacin
The serum concentration of Grepafloxacin can be decreased when it is combined with Iron.
Hydrotalcite
Hydrotalcite can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Imidapril
Iron can cause a decrease in the absorption of Imidapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lansoprazole
Lansoprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Levodopa
The serum concentration of Levodopa can be decreased when it is combined with Iron.
Levofloxacin
The serum concentration of Levofloxacin can be decreased when it is combined with Iron.
Levofloxacin Anhydrous
The serum concentration of Levofloxacin can be decreased when it is combined with Iron.
Levothyroxine
The serum concentration of Levothyroxine can be decreased when it is combined with Iron.
Lisinopril
Iron can cause a decrease in the absorption of Lisinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Lisinopril Anhydrous
Iron can cause a decrease in the absorption of Lisinopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magaldrate
Magaldrate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Hydroxide
Magnesium hydroxide can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Oxide
Magnesium oxide can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Magnesium Trisilicate
Magnesium Trisilicate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methantheline
Methantheline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Methyldopa
The serum concentration of Methyldopa can be decreased when it is combined with Iron.
METHYLDOPA ANHYDROUS
The serum concentration of Methyldopa can be decreased when it is combined with Iron.
Minocycline
Minocycline can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Moexipril
Iron can cause a decrease in the absorption of Moexipril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Nalidixic Acid
The serum concentration of Nalidixic Acid can be decreased when it is combined with Iron.
Nizatidine
Nizatidine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Norfloxacin
The serum concentration of Norfloxacin can be decreased when it is combined with Iron.
Olanzapine
Olanzapine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Omeprazole
Omeprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pancreatin
Pancrelipase can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pancrelipase
Pancrelipase can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
PANCRELIPASE PROTEASE
Pancrelipase can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pantoprazole
Pantoprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pefloxacin
The serum concentration of Pefloxacin can be decreased when it is combined with Iron.
Penicillamine
Iron can cause a decrease in the absorption of Penicillamine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Perindopril
Iron can cause a decrease in the absorption of Perindopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Promethazine
Promethazine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Quinapril
Iron can cause a decrease in the absorption of Quinapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rabeprazole
Rabeprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ramipril
Iron can cause a decrease in the absorption of Ramipril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ranitidine
Ranitidine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rescinnamine
Iron can cause a decrease in the absorption of Rescinnamine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Rosoxacin
The serum concentration of Rosoxacin can be decreased when it is combined with Iron.
Roxatidine Acetate
Roxatidine acetate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Bicarbonate
Sodium bicarbonate can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium glycerophosphate
Iron can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM GLYCEROPHOSPHATE ANHYDROUS
Iron can cause a decrease in the absorption of Sodium glycerophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate
Iron can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sodium Phosphate, Monobasic
Iron can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Iron can cause a decrease in the absorption of Sodium phosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Sparfloxacin
The serum concentration of Sparfloxacin can be decreased when it is combined with Iron.
Spirapril
Iron can cause a decrease in the absorption of Spirapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Temafloxacin
The serum concentration of Temafloxacin can be decreased when it is combined with Iron.
Thioctic Acid
Iron can cause a decrease in the absorption of Lipoic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trandolapril
Iron can cause a decrease in the absorption of Trandolapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trientine
The serum concentration of Iron can be decreased when it is combined with Triethylenetetramine.
Tromethamine
Tromethamine can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy.
Trovafloxacin
The serum concentration of Trovafloxacin can be decreased when it is combined with Iron.
Zofenopril
Iron can cause a decrease in the absorption of Zofenopril resulting in a reduced serum concentration and potentially a decrease in efficacy.
